Apoptosis and inflammation

Abstract

During the last few decades it has been recognized that cell death is not the consequence of accidental injury, but is the expression of a cell suicide programme. Kerr et al. (1972) introduced the term apoptosis. This form of cell death is under the influence of hormones, growth factors and cytokines, which depending upon the receptors present on the target cells, may activate a genetically controlled cell elimination process. During apoptosis the cell membrane remains intact and the cell breaks into apoptotic bodies, which are phagocytosed. Apoptosis, in contrast to necrosis, is not harmful to the host and does not induce any inflammatory reaction. The principal event that leads to inflammatory disease is cell damage, induced by chemical/physical injury, anoxia or starvation. Cell damage means leakage of cell contents into the adjacent tissues, resulting in the capillary transmigration of granulocytes to the injured tissue. The accumulation of neutrophils and release of enzymes and oxygen radicals enhances the inflammatory reaction. Until now there has been little research into the factors controlling the accumulation and the tissue load of granulocytes and their histotoxic products in inflammatory processes. Neutrophil apoptosis may represent an important event in the control of intlamtnation. It has been assumed that granulocytes disintegrate to apoptotic bodies before their fragments are removed by local macrophages. Removal of neutrophils from the inflammatory site without release of granule contents is of paramount importance for cessation of inflammation. In conclusion, apoptotic cell death plays an important role in inflammatory processes and in the resolution of inflammatory reactions. The facts known at present should stimulate further research into the role of neutrophil, eosinophil and macrophage apoptosis in inflammatory diseases.

References 113

1. 1.

   Alison M. R., Sarraf C. E. Apoptosis: a gene-directed programme of cell death. J R Coll Physicians Lond. 1992;26(1):25-35.

   Not in our library

2. 2.

   Ameisen J. C., Capron A. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol Today. 1991;12(4):102-105.

   Not in our library10.1016/0167-5699(91)90092-8

3. 3.

   Araki S., Shimada Y., Kaji K., Hayashi H. Apoptosis of vascular endothelial cells by fibroblast growth factor deprivation. Biochem Biophys Res Commun. 1990;168(3):1194-1200.

   Not in our library10.1016/0006-291x(90)91155-l

4. 4.

   Barres B. A., Hart I. K., Coles H. S., Burne J. F., Voyvodic J. T., Richardson W. D., Raff M. C. Cell death and control of cell survival in the oligodendrocyte lineage. Cell. 1992;70(1):31-46.

   Not in our library10.1016/0092-8674(92)90531-g

5. 5.

   Begley C. G., Lopez A. F., Nicola N. A., Warren D. J., Vadas M. A., Sanderson C. J., Metcalf D. Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors. Blood. 1986;68(1):162-166.

   Not in our library

6. 6.

   Bishop C. J., Moss D. J., Ryan J. M., Burrows S. R. T lymphocytes in infectious mononucleosis. II. Response in vitro to interleukin-2 and establishment of T cell lines. Clin Exp Immunol. 1985;60(1):70-77.

   Not in our library

7. 7.

   Bonta I. L., Ben-Efraim S. Involvement of inflammatory mediators in macrophage antitumor activity. J Leukoc Biol. 1993;54(6):613-626.

   Not in our library10.1002/jlb.54.6.613

8. 8.

   Cohen J. J. Apoptosis. Immunol Today. 1993;14(3):126-130.

   Not in our library10.1016/0167-5699(93)90214-6

9. 9.

   Cohen J. J., Duke R. C., Fadok V. A., Sellins K. S. Apoptosis and programmed cell death in immunity. Annu Rev Immunol. 1992;10:267-293.

   Not in our library10.1146/annurev.iy.10.040192.001411

10. 10.

    Collins M. K., Marvel J., Malde P., Lopez-Rivas A. Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. J Exp Med. 1992;176(4):1043-1051.

    Not in our library10.1084/jem.176.4.1043

11. 11.

    Collins M. K., Marvel J., Malde P., Lopez-Rivas A. Interleukin 3 protects murine bone marrow cells from apoptosis induced by DNA damaging agents. J Exp Med. 1992;176(4):1043-1051.

    Not in our library10.1084/jem.176.4.1043

12. 12.

    Dieken E. S., Miesfeld R. L. Transcriptional transactivation functions localized to the glucocorticoid receptor N terminus are necessary for steroid induction of lymphocyte apoptosis. Mol Cell Biol. 1992;12(2):589-597.

    Not in our library10.1128/mcb.12.2.589-597.1992

13. 13.

    Dinarello C. A., Wolff S. M. The role of interleukin-1 in disease. N Engl J Med. 1993;328(2):106-113.

    Not in our library10.1056/nejm199301143280207

14. 14.

    Drago J., Murphy M., Carroll S. M., Harvey R. P., Bartlett P. F. Fibroblast growth factor-mediated proliferation of central nervous system precursors depends on endogenous production of insulin-like growth factor I. Proc Natl Acad Sci U S A. 1991;88(6):2199-2203.

    Not in our library10.1073/pnas.88.6.2199

15. 15.

    Duke R. C., Cohen J. J. IL-2 addiction: withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Res. 1986;5(4):289-299.

    Not in our library

16. 16.

    Edwards S. N., Buckmaster A. E., Tolkovsky A. M. The death programme in cultured sympathetic neurones can be suppressed at the posttranslational level by nerve growth factor, cyclic AMP, and depolarization. J Neurochem. 1991;57(6):2140-2143.

    Not in our library10.1111/j.1471-4159.1991.tb06434.x

17. 17.

    Ellis R. E., Yuan J. Y., Horvitz H. R. Mechanisms and functions of cell death. Annu Rev Cell Biol. 1991;7:663-698.

    Not in our library10.1146/annurev.cb.07.110191.003311

18. 18.

    Evan G. I., Littlewood T. D. The role of c-myc in cell growth. Curr Opin Genet Dev. 1993;3(1):44-49.

    Not in our library10.1016/s0959-437x(05)80339-9

19. 19.

    Evan G. I., Wyllie A. H., Gilbert C. S., Littlewood T. D., Land H., Brooks M., Waters C. M., Penn L. Z., Hancock D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 1992;69(1):119-128.

    Not in our library10.1016/0092-8674(92)90123-t

20. 20.

    Fesus L. Apoptosis. Immunol Today. 1992;13(8):A16-A17.

    Not in our library10.1016/0167-5699(92)90059-g

21. 21.

    Golstein P., Ojcius D. M., Young J. D. Cell death mechanisms and the immune system. Immunol Rev. 1991;121:29-65.

    Not in our library10.1111/j.1600-065x.1991.tb00822.x

22. 22.

    Gottlieb E., Haffner R., von Rüden T., Wagner E. F., Oren M. Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J. 1994;13(6):1368-1374.

    Not in our library10.1002/j.1460-2075.1994.tb06390.x

23. 23.

    Gougeon M. L., Olivier R., Garcia S., Guetard D., Dragic T., Dauguet C., Montagnier L. Mise en évidence d'un processus d'engagement vers la mort cellulaire par apoptose dans les lymphocytes de patients infectés par le VIH. C R Acad Sci III. 1991;312(11):529-537.

    Not in our library

24. 24.

    Groux H., Torpier G., Monté D., Mouton Y., Capron A., Ameisen J. C. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med. 1992;175(2):331-340.

    Not in our library10.1084/jem.175.2.331

25. 25.

    Harrington E. A., Bennett M. R., Fanidi A., Evan G. I. c-Myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 1994;13(14):3286-3295.

    Not in our library10.1002/j.1460-2075.1994.tb06630.x

26. 26.

    Haslett C. Resolution of acute inflammation and the role of apoptosis in the tissue fate of granulocytes. Clin Sci (Lond). 1992;83(6):639-648.

    Not in our library10.1042/cs0830639

27. 27.

    Hefti F., Knusel B. Chronic administration of nerve growth factor and other neurotrophic factors to the brain. Neurobiol Aging. 1988;9(5-6):689-690.

    Not in our library10.1016/s0197-4580(88)80133-7

28. 28.

    Henderson S., Rowe M., Gregory C., Croom-Carter D., Wang F., Longnecker R., Kieff E., Rickinson A. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell. 1991;65(7):1107-1115.

    Not in our library10.1016/0092-8674(91)90007-l

29. 29.

    Her E., Frazer J., Austen K. F., Owen W. F. Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J Clin Invest. 1991;88(6):1982-1987.

    Not in our library10.1172/jci115524

30. 30.

    Hernández-Caselles T., Stutman O. Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation. J Immunol. 1993;151(8):3999-4012.

    Not in our library

31. 31.

    Hogquist K. A., Nett M. A., Unanue E. R., Chaplin D. D. Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci U S A. 1991;88(19):8485-8489.

    Not in our library10.1073/pnas.88.19.8485

32. 32.

    Hollstein M., Sidransky D., Vogelstein B., Harris C. C. p53 mutations in human cancers. Science. 1991;253(5015):49-53.

    Not in our library10.1126/science.1905840

33. 33.

    Itoh N., Nagata S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem. 1993;268(15):10932-10937.

    Not in our library

34. 34.

    Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hase A., Seto Y., Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 1991;66(2):233-243.

    Not in our library10.1016/0092-8674(91)90614-5

35. 35.

    Jacobson M. D., Burne J. F., Raff M. C. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J. 1994;13(8):1899-1910.

    Not in our library10.1002/j.1460-2075.1994.tb06459.x

36. 36.

    Kabelitz D., Pohl T., Pechhold K. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today. 1993;14(7):338-339.

    Not in our library10.1016/0167-5699(93)90231-9

37. 37.

    Kamb A., Gruis N. A., Weaver-Feldhaus J., Liu Q., Harshman K., Tavtigian S. V., Stockert E., Day R. S., Johnson B. E., Skolnick M. H. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 1994;264(5157):436-440.

    Not in our library10.1126/science.8153634

38. 38.

    Kannan Y., Usami K., Okada M., Shimizu S., Matsuda H. Nerve growth factor suppresses apoptosis of murine neutrophils. Biochem Biophys Res Commun. 1992;186(2):1050-1056.

    Not in our library10.1016/0006-291x(92)90853-d

39. 39.

    Kappler J. W., Roehm N., Marrack P. T cell tolerance by clonal elimination in the thymus. Cell. 1987;49(2):273-280.

    Not in our library10.1016/0092-8674(87)90568-x

40. 40.

    Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 1991;51(23 Pt 1):6304-6311.

    Not in our library

Cited by papers we hold 1

• Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review · 2022
  Not checked

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.